ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,034.91
      -0.30%
      US Tech 100
      20,835.20
      -0.29%
      Dow Jones
      44,247.83
      -0.35%
      Brent Oil
      72.425
      0.67%
      Bitcoin
      97,259.90
      0.60%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cytek Biosciences Inc (CTKB) Quote

      Cytek Biosciences Inc

      Cytek Biosciences Inc (CTKB)

      NASDAQ
      6.73
      -0.07
      (-1.03%)
      Closed December 10 4:00PM
      Delayed by 15 minutes
      6.73
      0.00
      (0.00%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      6.73
      Bid
      6.44
      Ask
      6.83
      Volume
      638,572
      6.63 Day's Range 6.89
      4.66 52 Week Range 9.87
      Market Cap
      866.895M
      Previous Close
      6.80
      Open
      6.83
      Last Trade
      2108
      @
      6.73
      (priorref)
      Last Trade Time
      Financial Volume
      $ 4,328,630
      VWAP
      6.7786
      Average Volume (3m)
      683,804
      Shares Outstanding
      128,810,614
      Dividend Yield
      -
      PE Ratio
      -71.37
      Earnings Per Share (EPS)
      -0.09
      Revenue
      193.02M
      Net Profit
      -12.15M

      About Cytek Biosciences Inc

      Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-co... Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Show more

      Sector
      Lab Analytical Instruments
      Industry
      Lab Analytical Instruments
      Website
      www.cytekbio.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Cytek Biosciences Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker CTKB. The last closing price for Cytek Biosciences was $6.80. Over the last year, Cytek Biosciences shares have traded in a share price range of $ 4.66 to $ 9.87.

      Cytek Biosciences currently has 128,810,614 shares outstanding. The market capitalization of Cytek Biosciences is $875.91 million. Cytek Biosciences has a price to earnings ratio (PE ratio) of -71.37.

      Ask ADVFN Intelligence (AI)

      CTKB Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 20 2024
      Edgar (US Regulatory)

      Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

      FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...

      November 20 2024
      GlobeNewswire Inc.

      Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

      FREMONT, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that it has been named “Overall BioTech Company of the Year” in the fourth annual...

      November 19 2024
      GlobeNewswire Inc.

      Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

      FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This...

      November 07 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      November 05 2024
      Edgar (US Regulatory)

      Cytek Biosciences Reports Third Quarter 2024 Financial Results

      FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...

      November 05 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.15-2.180232558146.886.96.4155839606.66623461CS
      4-0.4-5.610098176727.137.235.686171316.52955895CS
      121.5529.92277992285.187.634.666838045.9813639CS
      260.8915.23972602745.847.634.666433105.85434871CS
      52-0.93-12.14099216717.669.874.666834916.68154089CS
      156-12.56-65.111456713319.2919.683.88127679.28401773CS
      260-13.37-66.517412935320.128.73.87518549.86387901CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CMRXChimerix Inc
      $ 2.77
      (220.23%)
      		180.68M
      QUREuniQure NV
      $ 15.30
      (109.73%)
      		61.48M
      CPIXCumberland Pharmaceutical Inc
      $ 2.44
      (96.77%)
      		91.6M
      RDZNRoadzen Inc
      $ 2.5901
      (56.98%)
      		3.41M
      CRDFCardiff Oncology Inc
      $ 3.77
      (54.51%)
      		48.06M
      CRVOCervoMed Inc
      $ 2.1598
      (-78.93%)
      		8.17M
      BIORBiora Therapeutics Inc
      $ 0.55
      (-59.26%)
      		1.88M
      MRMMEDIROM Healthcare Technologies Inc
      $ 1.60
      (-42.86%)
      		1.73M
      HWHHWH International Inc
      $ 0.62
      (-38.61%)
      		9.54M
      HUIZHuize Holding Ltd
      $ 4.08
      (-32.67%)
      		424.8k
      ICCTiCoreConnect Inc
      $ 0.2103
      (13.37%)
      		308.54M
      RGTIRigetti Computing Inc
      $ 6.4994
      (45.40%)
      		246.84M
      NVDANVIDIA Corporation
      $ 135.07
      (-2.69%)
      		205.89M
      CMRXChimerix Inc
      $ 2.77
      (220.23%)
      		180.68M
      XTIAXTI Aerospace Inc
      $ 0.043
      (-1.15%)
      		165.98M

      Discussion

      View Full Feed
      badog badog 3 minutes ago
      Am I seeing the Christmas surprise? SP down 65% today?

      Badog
      ERHE
      KevGee59 KevGee59 4 minutes ago
      You could've also bought as many shares as you are going to sell at the end of the year 30 days prior. Then sell the FIFO shares for a loss. But still have the same amount of shares that you had to begin with. Only you can take the loss for this year...and perhaps average down at the same time.
      NWBO
      Zorch305 Zorch305 4 minutes ago
      Just by lvl2 observation its kinda obvious it was bought quite a bit over the past year so we'll see if they ever file
      RNVA
      1vman 1vman 5 minutes ago
      *****💩HCMC💩 Heading back 2Court with a far weaker case - lawsuit to bankrupt company ??? chances of wining are very very slim 2none

      ENOUGH SAID🤔 !!! HUZZAH🤔 !!!
      HCMC
      KILLAZILLA KILLAZILLA 6 minutes ago
      LOLOLOLOL......

      Judging by "your" posts....

      NO COMMENT NECESSARY!!!!

      I didn't forget the bold and italics this time....
      INQD
      1vman 1vman 7 minutes ago
      *****💩GNCP💩 Ticker to be revoked soon as interest has faded to none here

      ENOUGH SAID !!!
      GNCP
      skitahoe skitahoe 7 minutes ago
      Flipper, while I didn't actually add that many shares, I added enough to sell those that were at a significant price above the current price.

      It's really never been my intent to sell, rather to have it pass to my kids who'd get a new tax basis, but I can't control what would happen if
      NWBO
      1vman 1vman 7 minutes ago
      *****🚽HCWC🚽 Has 33,182,124 million share holder deficit , net losses increasing

      this is a stay far away from garbage stock

      https://www.otcmarkets.com/filing/conv_pdf?id=17968641&guid=aBY-kpqXejwfJth

      ENOUGH SAID HUZZAH🤪 !!!
      HCWC
      firebag1 firebag1 8 minutes ago
      Well the merger with Kaboomraks ain’t gonna hurt it
      CGAC
      1vman 1vman 9 minutes ago
      *****🚽HIRU🚽Next to zero interest here - volume shriveling up as the downside continues merrily along

      https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/historical


      HUZZAH🤔 !!! ENOUGH SAID🤔 !!!
      HIRU
      norisknorewards norisknorewards 9 minutes ago
      Lolol what a disparate attempt to get longs to sell b4 a decision.

      Love it that that's what you chimed in for
      NWBO
      firebag1 firebag1 9 minutes ago
      CGAC! Pink Current
      CGAC
      pos_stock_hoarder pos_stock_hoarder 10 minutes ago
      And oldie but a goldie......
      https://willyorwonthe.wordpress.com/wp-content/uploads/2023/12/img_9830.jpg?w=600
      StayHumble StayHumble 10 minutes ago
      w0w 6Digit .000001 Buys Huzzah!💹Facts Matter Sometimes💹
      https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades
      HCMC
      MakinBank MakinBank 11 minutes ago
      don't avoid addressing what I posted. I am not disillusioned. management sucks and selling for a loss needs to be done with tax strategy. Now about, what I posted?
      AUNXF
      north40000 north40000 11 minutes ago
      The article is dated in May 2022, and the trial is then underway with further patients to be added during that trial in U.K., England. A 2 year trial will end sometime in 2024-2025, doing that math. Vascepa was donated for the trial by Amarin, free of charge.
      AMRN
      Gnarlyman Gnarlyman 11 minutes ago
      What does CognoGroup's 10% equity stake equate to for a company with a $1Billion Valuation? I'm genuinely being serious with this question. 

      https://x.com/jessetinsley/status/1866683648327721
      AESO
      1vman 1vman 11 minutes ago
      *****🟥🟥🟥 DBMMs PEO Linda needs to explain under oath in a court room the discrepancies of salary collected in financials 👍️

      ENOUGH SAID HUZZAH🤔 !!!
      DBMM
      getmoreshares getmoreshares 12 minutes ago
      DELAY REVEALED --Amendment to Quarterly Report Quarterly Report - 3rd Quarter 2024
      for 09/30/2024 originally published through the OTC Disclosure & News
      Service on 11/25/2024
      Explanatory Note:
      Retained earnings/ Accumulated defcit listed on Balance sheet does not does not
      CGAC
      KILLAZILLA KILLAZILLA 13 minutes ago
      3 POST "WONDERFUL" PERSON THAT WAS CORRECT ALL ALONG.....

      you're WELCOME BTW....
      INQD
      JPS02 JPS02 13 minutes ago
      Hopefully CGAC is turning the corner this time and can rebound with a good business model.
      CGAC
      JPS02 JPS02 13 minutes ago
      In October 2023, the Board of Directors and Majority Shareholder authorized a 1:300 reverse split of the Company’s common stock. However, effective November 1, 2024, this reverse split was abandoned.

      Source - page 2: https://www.otcmarkets.com/otcapi/company/financial-report/418957/co
      CGAC
      StayHumble StayHumble 14 minutes ago
      💹💹wow!Lots of interest here in $GNCP!💹💹💹💹
      GNCP
      ron_66271 ron_66271 14 minutes ago
      IMO, The FDIC Will Release Their Lien on the RE.

      Yes, The February MOR of ~+$25 Billion split 75/25% between Class 19/22.

      Yes this must happen first.


      As the LIBOR litigation closes, the FDIC is expected to release its hold on WMI assets.
      COOP

      Your Recent History

      NASDAQ
      CTKB
      Cytek Biosciences
      Delayed Upgrade Clock